Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE
Equities
IL0006290147
Pharmaceuticals
Sales 2024 * | 15.95B 5,881B | Sales 2025 * | 16.52B 6,089B | Capitalization | 19.01B 7,006B |
---|---|---|---|---|---|
Net income 2024 * | 820M 302B | Net income 2025 * | 1.39B 511B | EV / Sales 2024 * | 2.13 x |
Net Debt 2024 * | 14.93B 5,501B | Net Debt 2025 * | 12.41B 4,574B | EV / Sales 2025 * | 1.9 x |
P/E ratio 2024 * |
17.8
x | P/E ratio 2025 * |
12.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.71% |
Latest transcript on Teva Pharmaceutical Industries Limited
Managers | Title | Age | Since |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 22-12-31 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 19-12-21 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 15-08-31 |
Janet Vergis
BRD | Director/Board Member | 59 | 20-06-08 |
Sol Barer
CHM | Chairman | 76 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
+35.01% | 709B | |
+29.59% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.60% | 239B | |
+9.32% | 211B | |
-3.68% | 203B | |
+10.77% | 171B |